3 months ago
XERS
AnalystsBrandon FolkesBrandon Folkes's Stock Forecasts
AnalystsBrandon Folkes
Analyst Ranking
Bottom 5%
#4851 out of 5081 analysts
Average Return
-4.73%
Win Rate
43%36 out of 83
Risk vs Reward
Poor
Good
Brandon Folkes's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Elutia IncELUT | +130.77% | $1.43 | $3.30 | 2023-08-14 - 2024-08-14 | Strong Buy |
Trevi Therapeutics IncTRVI | +122.74% | $2.77 | $6.17 | 2024-06-12 - 2025-06-12 | Strong Buy |
Cormedix IncCRMD | +118.98% | $6.27 | $13.73 | 2024-08-25 - 2025-08-25 | Strong Buy |
Eupraxia Pharmaceuticals IncEPRX | +87.59% | $2.90 | $5.44 | 2024-11-13 - 2025-10-29 | Strong Buy |
Connect Biopharma Holdings LtdCNTB | +86.24% | $0.85 | $1.58 | 2025-06-11 - 2025-10-29 | Buy |
Brandon Folkes Analyst Color
Get additional color on Brandon Folkes's coverage of popular stocks
Brandon Folkes's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rani Therapeutics Holdings IncRANI | 3 | Buy | $11.00 | +562.65% | Assumes | 9 days ago |
Omeros CorpOMER | 2 | Buy | $20.00 | +160.42% | Maintains | 15 days ago |
Mannkind CorpMNKD | 6 | Buy | $11.00 | +98.56% | Reiterates | 17 days ago |
Genfit SaGNFT | 2 | Buy | $7.00 | +67.06% | Maintains | a month ago |
Rein Therapeutics IncRNTX | 1 | Buy | $10.00 | +545.16% | Initiates Coverage On | a month ago |
Ani Pharmaceuticals IncANIP | 5 | Buy | $121.00 | +31.19% | Maintains | a month ago |
Valneva SeVALN | 2 | Buy | $18.00 | +97.37% | Reiterates | 2 months ago |
Journey Medical CorpDERM | 2 | Buy | $13.00 | +63.73% | Initiates Coverage On | 2 months ago |
Achieve Life Sciences IncACHV | 2 | Buy | $12.00 | +142.42% | Initiates Coverage On | 2 months ago |
Eupraxia Pharmaceuticals IncEPRX | 3 | Buy | $12.00 | +120.59% | Reiterates | 2 months ago |
Polypid LtdPYPD | 4 | Buy | $13.00 | +242.11% | Reiterates | 3 months ago |
Connect Biopharma Holdings LtdCNTB | 2 | Buy | $7.00 | +342.20% | Reiterates | 3 months ago |
Xeris Biopharma Holdings IncXERS | 1 | Buy | $10.00 | +3.95% | Assumes | 3 months ago |
Collegium Pharmaceutical IncCOLL | 4 | Buy | $44.00 | +26.40% | Assumes | 3 months ago |
Cormedix IncCRMD | 3 | Buy | $17.00 | +50.31% | Maintains | 3 months ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $29.00 | +248.14% | Assumes | 3 months ago |
Indivior PLCINDV | 1 | Buy | $28.00 | +10.94% | Initiates Coverage On | 3 months ago |
Enanta Pharmaceuticals IncENTA | 1 | Buy | $20.00 | +88.15% | Assumes | 3 months ago |
Zevra Therapeutics IncZVRA | 1 | Buy | $26.00 | +156.92% | Initiates Coverage On | 4 months ago |
Heron Therapeutics IncHRTX | 2 | Buy | $6.00 | +412.82% | Initiates Coverage On | 5 months ago |
Milestone Pharmaceuticals IncMIST | 2 | Buy | $5.00 | +171.74% | Assumes | 5 months ago |
Cardiol Therapeutics IncCRDL | 1 | Buy | $9.00 | +689.47% | Initiates Coverage On | 5 months ago |
Trevi Therapeutics IncTRVI | 2 | Buy | $21.00 | +98.49% | Initiates Coverage On | 5 months ago |
Rockwell Medical IncRMTI | 1 | Strong Buy | $5.00 | +358.72% | Initiates Coverage On | a year ago |
Adial Pharmaceuticals IncADIL | 1 | Strong Buy | $8.00 | +2,185.71% | Initiates Coverage On | a year ago |
Emergent Biosolutions IncEBS | 4 | Strong Buy | $16.00 | N/A | Reiterates | a year ago |
Scilex Holding CoSCLX | 1 | Strong Buy | $455.00 | N/A | Initiates Coverage On | a year ago |
Sanara Medtech IncSMTI | 4 | Strong Buy | $59.00 | N/A | Reiterates | 2 years ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $180.00 | N/A | Reiterates | 2 years ago |
Elutia IncELUT | 3 | Strong Buy | $8.00 | N/A | Reiterates | 2 years ago |
Amryt Pharma PLCAMYT | 2 | Hold | $14.75 | N/A | Downgrades | 3 years ago |
Veru IncVERU | 3 | Strong Buy | $220.00 | N/A | Maintains | 3 years ago |
Sorrento Therapeutics IncSRNEQ | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | 3 years ago |
Obseva SaOBSVF | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Alkermes PLCALKS | 1 | Strong Buy | $32.00 | N/A | Upgrades | 4 years ago |
IMV IncIMVIQ | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Redhill Biopharma LtdRDHL | 1 | Strong Buy | $22,000.00 | N/A | Initiates Coverage On | 4 years ago |
Trevena IncTRVN | 1 | Strong Buy | $3,125.00 | N/A | Initiates Coverage On | 5 years ago |
Optinose IncOPTN | 3 | Strong Buy | $315.00 | N/A | Reiterates | 6 years ago |
Eagle Pharmaceuticals IncEGRX | 2 | Hold | $46.00 | N/A | Maintains | 6 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $30.00 | N/A | Reiterates | 6 years ago |
Opiant Pharmaceuticals IncOPNT | 1 | Strong Buy | $42.00 | N/A | Maintains | 7 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Strong Buy | $50.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.